Approval · Notice of Compliance 27234 · 2021
FENTORA: Notice of Compliance 27234
Issued December 14, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27234
- Date
- December 14, 2021
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph and migrate the Product Monograph to the 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FENTORA | Not yet assigned | — |
Medicinal ingredients
- FENTANYL CITRATE 100 MCG per TAB
- FENTANYL CITRATE 200 MCG per TAB
- FENTANYL CITRATE 400 MCG per TAB
- FENTANYL CITRATE 600 MCG per TAB
- FENTANYL CITRATE 800 MCG per TAB